Dermatology (Basel, Switzerland) · 2003
Alteration and significance of heparin-binding epidermal-growth-factor-like growth factor in psoriatic epidermis.
Сравнительное исследованиеСтатьяНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zheng Yan, Peng Zhenhui, Wang Yili, Tan Shengshun, Xi Yanping, Wang Guorong
Аннотация
BACKGROUND: Heparin-binding epidermal-growth-factor-like growth factor (HB-EGF) has proved to be a mitogen of keratinocytes, which may be involved in the pathogenesis of inflammatory diseases, but its mechanism in psoriasis remains unknown.
OBJECTIVE: To investigate the alteration of HB-EGF in the epidermis of active psoriasis vulgaris.
METHODS: The expression of HB-EGF in normal skin tissues, uninvolved tissues and psoriatic lesions was detected by in situ hybridization and immunohistochemistry.
RESULTS: HB-EGF mRNA and protein were located in the basal layer of normal epidermis (10/10, 100.00%), with nearly no expression in the suprabasal layers (1/10, 10.00%); the expression of HB-EGF was located not only in the basal layer (21/21, 100.00%), but was also seen as focal overexpression in the suprabasal layers of uninvolved epidermis (20/21, 95.24%) and the marginal part of psoriatic lesions (18/21, 85.71%), while nearly no expression of HB-EGF was found in the central part of psoriatic lesions (1/21, 4.76%).
CONCLUSION: HB-EGF may play an important role in the early pathogenesis of psoriasis.
OBJECTIVE: To investigate the alteration of HB-EGF in the epidermis of active psoriasis vulgaris.
METHODS: The expression of HB-EGF in normal skin tissues, uninvolved tissues and psoriatic lesions was detected by in situ hybridization and immunohistochemistry.
RESULTS: HB-EGF mRNA and protein were located in the basal layer of normal epidermis (10/10, 100.00%), with nearly no expression in the suprabasal layers (1/10, 10.00%); the expression of HB-EGF was located not only in the basal layer (21/21, 100.00%), but was also seen as focal overexpression in the suprabasal layers of uninvolved epidermis (20/21, 95.24%) and the marginal part of psoriatic lesions (18/21, 85.71%), while nearly no expression of HB-EGF was found in the central part of psoriatic lesions (1/21, 4.76%).
CONCLUSION: HB-EGF may play an important role in the early pathogenesis of psoriasis.
Предметные рубрики MeSH
AdolescentAdultBase SequenceBiopsy, NeedleCase-Control StudiesEpidermal Growth FactorFemaleGenetic MarkersGenetic Predisposition to DiseaseHeparin-binding EGF-like Growth FactorHumansImmunohistochemistryIn Situ HybridizationIntercellular Signaling Peptides and ProteinsMaleMiddle AgedMolecular Sequence DataPolymerase Chain ReactionPrognosisPsoriasisRNA, MessengerReference ValuesSensitivity and SpecificitySeverity of Illness Index